Else Nutrition Holdings Inc (BABYF)

[pual]

BABY -onference18-11-2021 (An abstract)
*"Empire's take time to build" - CEO
*"Big things happening in 2022" -CEO
*"Very profitable in next 2-3 years"
*listed on TSX in CANADA Jan 20, 2022
*they will be diluting again, they have 23 million in cash right now
*FDA approval - clinical trial starts March 2022, ends in Q3 2023
*Else will be cash positive most likely 2-3 years from now
*expanding scientific advisory board, even more, to help get permit from the FDA
*No plans to split shares on uplisting
*Else does not want to be a manufacturing company but they will own their own equipment.
*Airing a commercial in Q1 2022
*they are going to partner with someone in China and create a team to market there
*Else has about 30-32 total employees
*Yes Srategic partnerships on the horizon, she can't talk about it
* ...
REMINDER: This was more than 2 years ago.